Florbetapir positron emission tomography and cerebrospinal fluid biomarkers

BACKGROUND: We evaluated the relationship between florbetapir-F18 positron emission tomography (FBP PET) and cerebrospinal fluid (CSF) biomarkers. METHODS: Alzheimer’s Disease Neuroimaging Initiative (ADNI)-GO/2 healthy control (HC), mild cognitive impairment (MCI), and Alzheimer’s disease (AD) deme...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Alzheimers Dement
Autors principals: Hake, Ann, Trzepacz, Paula T., Wang, Shufang, Yu, Peng, Case, Michael, Hochstetler, Helen, Witte, Michael M., Degenhardt, Elisabeth K., Dean, Robert A.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4544658/
https://ncbi.nlm.nih.gov/pubmed/25916563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2015.03.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars